share_log

UMB Bank N.a. Acquires 466 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

UMB Bank N.a. Acquires 466 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

UMB Bank N.A.收購直覺外科公司股份有限公司(納斯達克代碼:ISRG)466股
Defense World ·  2022/10/02 08:32

UMB Bank n.a. lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 10,208 shares of the medical equipment provider's stock after purchasing an additional 466 shares during the period. UMB Bank n.a.'s holdings in Intuitive Surgical were worth $2,049,000 at the end of the most recent reporting period.

UMB Bank n.a.根據納斯達克向美國證券交易委員會披露的最新信息,其在第二季度增持了美國證券交易委員會公司的股票4.8%。該基金在此期間額外購買了466股後,擁有這家醫療設備提供商的10,208股股票。在最近一個報告期結束時,聯合信貸銀行持有的直覺外科公司股份價值2,049,000美元。

Several other large investors also recently made changes to their positions in ISRG. Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of Intuitive Surgical by 7.9% during the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider's stock valued at $205,000 after acquiring an additional 50 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Intuitive Surgical by 0.9% during the first quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider's stock valued at $133,012,000 after acquiring an additional 3,982 shares during the period. MCIA Inc lifted its stake in shares of Intuitive Surgical by 5.6% during the first quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider's stock valued at $1,003,000 after acquiring an additional 190 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Intuitive Surgical by 2.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,616 shares of the medical equipment provider's stock valued at $7,550,000 after acquiring an additional 952 shares during the period. Finally, Raymond James Financial Services Advisors Inc. lifted its stake in shares of Intuitive Surgical by 0.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 88,814 shares of the medical equipment provider's stock valued at $26,793,000 after acquiring an additional 578 shares during the period. Institutional investors own 82.44% of the company's stock.

其他幾家大型投資者最近也改變了他們在ISRG的頭寸。今年第一季度,Mitchell McLeod Pugh&Williams Inc.增持的直覺外科公司股份增加了7.9%。Mitchell McLeod Pugh&Williams Inc.在此期間增持了50股,目前持有這家醫療設備提供商679股股票,價值20.5萬美元。今年第一季度,安維斯特資產管理公司增持的直覺外科公司股份增加了0.9%。Envestnet Asset Management Inc.在此期間額外收購了3982股,現在擁有440,904股這家醫療設備提供商的股票,價值133,012,000美元。今年第一季度,MCIA Inc.增持了5.6%的直覺外科公司股份。MCIA Inc.目前擁有這家醫療設備提供商3,596股股票,價值1,003,000美元,在此期間又購買了190股。三井住友DS資產管理有限公司在第二季度增持了2.6%的直覺外科公司股份。三井住友DS資產管理有限公司在此期間額外收購了952股,現在擁有這家醫療設備提供商37,616股股票,價值7,550,000美元。最後,雷蒙德·詹姆斯金融服務顧問公司(Raymond James Financial Services Advisors Inc.)在第一季度將直覺外科公司的持股比例提高了0.7%。雷蒙德·詹姆斯金融服務顧問公司(Raymond James Financial Services Advisors Inc.)目前持有這家醫療設備提供商88,814股股票,價值26,793,000美元,在此期間又購買了578股。機構投資者持有該公司82.44%的股票。

Get
到達
Intuitive Surgical
直覺外科公司
alerts:
警報:

Intuitive Surgical Stock Performance

直覺外科公司股票表現

NASDAQ:ISRG opened at $187.44 on Friday. The company has a market cap of $66.94 billion, a PE ratio of 47.69, a PEG ratio of 5.26 and a beta of 1.31. Intuitive Surgical, Inc. has a 52-week low of $184.94 and a 52-week high of $369.69. The stock has a 50-day simple moving average of $216.24 and a 200 day simple moving average of $229.94.

納斯達克:ISRG上週五開盤報187.44美元。該公司市值為669.4億美元,市盈率為47.69倍,聚乙二醇率為5.26倍,貝塔係數為1.31。直覺外科公司的股價為184.94美元,為52周低點,52周高點為369.69美元。該股的50日簡單移動均線切入位為216.24美元,200日簡單移動均線切入位為229.94美元。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter in the previous year, the business posted $1.42 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current fiscal year.
直覺外科公司(納斯達克代碼:ISRG-GET Rating)上一次發佈季度收益數據是在7月21日星期四。這家醫療設備供應商公佈本季度每股收益(EPS)為0.85美元,低於分析師普遍預期的1.04美元(0.19美元)。該公司本季度營收為15.2億美元,而市場普遍預期為15.6億美元。直覺外科公司的股本回報率為12.04%,淨利潤率為24.05%。在去年同期,該業務公佈的每股收益為1.42美元。研究分析師平均預測,直覺外科公司公司本財年每股收益將達到3.76歐元。

Wall Street Analysts Forecast Growth

華爾街分析師預測經濟增長

Several brokerages have recently issued reports on ISRG. Truist Financial cut their price target on Intuitive Surgical from $270.00 to $255.00 and set a "buy" rating on the stock in a research note on Friday, July 22nd. Raymond James cut their target price on Intuitive Surgical from $294.00 to $255.00 in a research note on Friday, July 22nd. Evercore ISI cut their target price on Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. Morgan Stanley cut their target price on Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a research note on Friday, July 15th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Intuitive Surgical from $225.00 to $205.00 in a research note on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $268.00.

幾家券商最近發佈了關於ISRG的報告。7月22日,Truist Financial將直覺外科公司的目標價從270.00美元下調至255.00美元,並在一份研究報告中對該股設定了“買入”評級。雷蒙德·詹姆斯在7月22日星期五的一份研究報告中將直覺外科公司的目標價從294.00美元下調至255.00美元。7月22日,週五,Evercore ISI在一份研究報告中將直覺外科公司的目標價從210.00美元下調至175.00美元。7月15日,摩根士丹利在一份研究報告中將直覺外科公司的目標價從300.00美元下調至225.00美元,並對該股設定了“同等權重”的評級。最後,德意志銀行在7月22日星期五的一份研究報告中將直覺外科公司的目標價從225.00美元下調至205.00美元。6名股票研究分析師對該股的評級為持有,12名分析師對該股的評級為買入。根據MarketBeat.com的數據,該公司目前的共識評級為“適度買入”,共識目標價為268.00美元。

Insider Buying and Selling

內幕買賣

In related news, EVP Myriam Curet sold 9,000 shares of the stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $48,825. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, EVP Myriam Curet sold 9,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $48,825. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 79,412 shares of the firm's stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total value of $17,176,815.60. Following the completion of the transaction, the chief executive officer now owns 54,607 shares of the company's stock, valued at $11,811,494.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 101,162 shares of company stock worth $22,062,916. 0.90% of the stock is owned by corporate insiders.

在相關新聞中,執行副總裁Myriam Curet在7月27日星期三的交易中出售了9000股該股。股票以225.00美元的平均價格出售,總成交金額為2,025,000.00美元。交易完成後,執行副總裁總裁現在直接持有該公司217股,價值48,825美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過這個環節。在直覺外科公司的另一則消息中,執行副總裁米里亞姆·庫雷特在7月27日(星期三)的一筆交易中出售了9000股該公司的股票。這隻股票的平均售價為225.00美元,總價值為2,025,000.00美元。交易完成後,執行副總裁總裁現在直接持有該公司217股,價值48,825美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過美國證券交易委員會網站。此外,在7月26日(星期二)的一次交易中,首席執行官加里·S·古薩特出售了79,412股公司股票。這些股票的平均價格為216.30美元,總價值為17,176,815.60美元。交易完成後,首席執行官現在擁有54,607股公司股票,價值11,811,494.10美元。關於這次銷售的披露可以找到這裏。在過去三個月裏,內部人士出售了101,162股公司股票,價值22,062,916美元。0.90%的股份由企業內部人士持有。

Intuitive Surgical Company Profile

直覺外科公司公司簡介

(Get Rating)

(獲取評級)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直覺外科公司公司開發、製造和營銷產品,使醫生和醫療保健提供者能夠在美國和國際上提高微創護理的質量和獲得微創護理的機會。該公司提供達芬奇外科系統,以實現使用微創方法進行復雜手術;以及離子腔內系統,將其商業產品從外科擴展到能夠進行微創肺活組織檢查的診斷程序。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • Let Paychex Stock Work Hard For You
  • 免費獲取斯托克新聞網關於直覺外科公司的研究報告
  • 電動汽車電池製造商Freyr將在全球大舉擴張
  • MarketBeat:回顧一週9/26-9/30
  • 這是買入美光科技的難忘時刻
  • 利潤下降對CarMax價值主張的挑戰
  • 讓Paychex股票為您努力工作

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直覺外科公司日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對直覺外科公司及相關公司的最新新聞和分析師評級的每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論